Volkow, Nora D.
National Institutes of Health · National Institute on Drug Abuse
181 papers on CoChatORCID 0000-0001-6668-0908
Most cited papers
- Verified
Genotype and ancestry modulate brain's DAT availability in healthy humans
Shumay, E., Chen, J., Fowler, J. S., & Volkow, N. D. (2011) · PLoS ONE
Neurotransmitter Receptor Influence on BehaviorGenetic Associations and Epidemiology
Cited by 58
- Verified
Emotion Recognition Biases in Alcohol Use Disorder
Freeman, C. R., Wiers, C. E., Sloan, M. E., Zehra, A., Ramirez, V., Wang, G., & Volkow, N. D. (2018) · Alcoholism: Clinical and Experimental Research
Substance Abuse Treatment and OutcomesFace Recognition and Perception
Cited by 57
- Verified
Semaglutide or tirzepatide and optic nerve and visual pathway disorders in type 2 diabetes
Wang, L., Volkow, N. D., Kaelber, D. C., & Xu, R. (2025) · JAMA Network Open
Diabetes Treatment and ManagementDrug-Induced Ocular Toxicity
Cited by 51
- Verified
Sensitivity to monetary reward is most severely compromised in recently abstaining cocaine addicted individuals: A cross-sectional ERP study
Parvaz, M. A., Maloney, T., Moeller, S. J., Woicik, P. A., Alia-Klein, N., Telang, F., Wang, G.-J., Squires, N. K., Volkow, N. D., & Goldstein, R. Z. (2012) · Psychiatry Research: Neuroimaging
Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes
Cited by 49
- Verified
Socioeconomic status is associated with striatal dopamine D2/D3 receptors in healthy volunteers but not in cocaine abusers
Wiers, C. E., Shokri-Kojori, E., Cabrera, E., Cunningham, S., Wong, C., Tomasi, D., Wang, G.-J., & Volkow, N. D. (2016) · Neuroscience Letters
Neurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment
Cited by 41
- Verified
Association of Severity of Adolescent Substance Use Disorders and Long-term Outcomes
Volkow, N. D., & Wargo, E. M. (2022) · JAMA Network Open
Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment
Cited by 29
- Verified
Regulation of novelty seeking by midbrain dopamine D2/D3 signaling and ghrelin is altered in obesity: Novelty Seeking in Obesity
Savage, S. W., Zald, D. H., Cowan, R. L., Volkow, N. D., Marks-Shulman, P. A., Kessler, R. M., Abumrad, N. N., & Dunn, J. P. (2014) · Obesity
Neurotransmitter Receptor Influence on BehaviorRegulation of Appetite and Obesity
Cited by 27
- Verified
Positron emission tomography radioligands for dopamine transporters and studies in human and nonhuman primates
Volkow, N. D., Fowler, J. S., Ding, Y.-S., Wang, G.-J., & Gatley, S. J. (1997) · Advances in Pharmacology
Neurotransmitter Receptor Influence on BehaviorRadiopharmaceutical Chemistry and Applications
Cited by 26
- Verified
Association Between Receipt of Antidepressants and Retention in Buprenorphine Treatment for Opioid Use Disorder: A Population-Based Retrospective Cohort Study
Zhang, K., Jones, C. M., Compton, W. M., Guy, G. P., Evans, M. E., & Volkow, N. D. (2022) · The Journal of Clinical Psychiatry
Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes
Cited by 22
- Verified
Severity of alcohol use disorder influences sex differences in sleep, mood, and brain functional connectivity impairments
Zhang, R., Wiers, C. E., Manza, P., Tomasi, D., Shokri-Kojori, E., Kerich, M., Almira, E., Schwandt, M., Diazgranados, N., Momenan, R., et al. (2022) · Brain Communications
Functional Brain Connectivity StudiesSubstance Abuse Treatment and Outcomes
Cited by 11
- Verified
How Academic Medicine Can Help Confront the Opioid Crisis
Volkow, N. D., McLellan, T., & Blanco, C. (2022) · Academic Medicine
Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes
Cited by 5
- Verified
High Levels of Dopamine D2 Receptors in Unaffected Members of Alcoholic Families: Possible Protective Factors
Volkow, N. D., Wang, G.-J., Begleiter, H., Porjesz, B., Fowler, J. S., Telang, F., Wong, C., Ma, Y., Logan, J., Goldstein, R., et al. (2006) · Archives of General Psychiatry
Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes
Cited by 2
- Verified
County-Level Variation in Substance Use Disorder Service Utilization by Insurance Payers and Self-Pay in the United States
Han, B., Compton, W. M., Jones, C. M., Stimson, D. T., Barfield, E. T., Bellgowan, J. F., Hobin, J. A., & Volkow, N. D. (2026) · The Journal of Clinical Psychiatry
Substance Abuse Treatment and OutcomesHealthcare Policy and Management
Cited by 0
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free